Detection of early neoplasia in Barrett’ esophagus: Do not focus on Barrett’s surveillance – diagnosis is at the indexendoscopy in SSBE with biopsies

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00004168

Enrollment

150

Registered

2012-06-06

Start date

2010-01-04

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C15.5

Interventions

Group 1: All patients who consecutively presented with a diagnosis of early neoplastic changes (high-grade intraepithelial neoplasia, esophageal adenocarcinoma) were recorded prospectively. The data n

Eligibility

Sex/Gender

All

Age

18 Years to 100 Years

Inclusion criteria

Inclusion criteria: all patients who consecutively presented with a diagnosis of early neoplastic changes (high-grade intraepithelial neoplasia, esophageal adenocarcinoma)

Exclusion criteria

Exclusion criteria: Lacking data of the criteria mentioned above.

Design outcomes

Primary

Measure	Time frame
All patients who consecutively presented with a diagnosis of early neoplastic changes (high-grade intraepithelial neoplasia, esophageal adenocarcinoma) were recorded prospectively. The data noted included the following: length of the Barrett’s segment, reason for esophagogastroduodenoscopy (EGD) at an external institution, external diagnosis, type of evidence of neoplasia (biopsy from a suspicious lesion, biopsy from a conspicuous but not suspicious lesion, four-quadrant biopsy), and diagnosis of macroscopic tumor type by performing an EGD at the expert center.	—

Measure

Time frame

All patients who consecutively presented with a diagnosis of early neoplastic changes (high-grade intraepithelial neoplasia, esophageal adenocarcinoma) were recorded prospectively. The data noted included the following: length of the Barrett’s segment, reason for esophagogastroduodenoscopy (EGD) at an external institution, external diagnosis, type of evidence of neoplasia (biopsy from a suspicious lesion, biopsy from a conspicuous but not suspicious lesion, four-quadrant biopsy), and diagnosis of macroscopic tumor type by performing an EGD at the expert center.

—

Secondary

Measure	Time frame
Is there any dependency of diagnosis of early neoplasia to length of BE or macroscopic tumor type?	—

Countries

Germany

Contacts

Public ContactAngelika Behrens

HSK

angelika.behrens@hsk-wiesbaden.de0049611432420

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026